A redundant role of human thyroid peroxidase propeptide for cellular, enzymatic, and immunological activity

Thyroid

Volumn 24, Issue 2, 2014, Pages 371-382

  Godlewska, Marlena ^a   Góra, Monika ^b   Buckle, Ashley M ^c   Porebski, Benjamin T ^c   Kemp, E Helen ^d   Sutton, Brian J ^e   Czarnocka, Barbara ^a   Banga, J Paul ^e  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^b INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; AUTOANTIBODIES; CATALYTIC DOMAIN; CHO CELLS; CRICETINAE; CRICETULUS; ENZYME PRECURSORS; GLYCOSYLATION; HUMANS; IODIDE PEROXIDASE; MOLECULAR DYNAMICS SIMULATION; PEROXIDASE; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; THYROID GLAND; THYROIDITIS, AUTOIMMUNE;

EID: 84894117574     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2013.0127     Document Type: Article

References (58)

1. Kopp P 2012 Thyroid hormone synthesis. In: Braverman LE, Cooper D (eds) Werner and Ingbar's the Thyroid: A Fundamental and Clinical Text. Tenth edition. Lippincott Williams & Wilkins, Philadelphia, pp 48-74.
2. Banga JP 1998 Developments in our understanding of the structure of thyroid peroxidase and the relevance of these findings to autoimmunity. Curr Opin Endocrinol Diabetes 5:275-281.
3. Gora M, Dubska M, Jastrzebska-Bohaterewicz E, Gardas A 2006 Profile of autoantibodies to the two immunodominant regions of thyroid peroxidase in autoimmunity. In: Wiersinga WM, Drexhage HA, Weetman AP, Butz S (eds) The Thyroid and Autoimmunity. Georg Thieme Verlag, New York, pp 110-117.
4. McLachlan SM, Rapoport B 2007 Thyroid peroxidase as an autoantigen. Thyroid 17:939-948.
5. Ruf J, Toubert ME, Czarnocka B, Durand-Gorde JM, Ferrand M, Carayon P 1989 Relationship between immunological structure and biochemical properties of human thyroid peroxidase. Endocrinology 125:1211-1218.
6. Czarnocka B, Janota-Bzowski M, McIntosh RS, Asghar MS, Watson PF, Kemp EH, Carayon P, Weetman AP 1997 Immunoglobulin G kappa antithyroid peroxidase antibodies in Hashimoto's thyroiditis: epitope-mapping analysis. J Clin Endocrinol Metab 82:2639-2644.
7. Chazenbalk GD, Portolano S, Russo D, Hutchison JS, Rapoport B, McLachlan S 1993 Human organ-specific autoimmune disease. Molecular cloning and expression of an autoantibody gene repertoire for a major autoantigen reveals an antigenic immunodominant region and restricted immunoglobulin gene usage in the target organ. J Clin Invest 92:62-74.
8. Dubska M, Banga JP, Plochocka D, Hoser G, Kemp EH, Sutton BJ, Gardas A, Gora M 2006 Structural insights into autoreactive determinants in thyroid peroxidase composed of discontinuous and multiple key contact amino acid residues contributing to epitopes recognized by patients' autoantibodies. Endocrinology 147:5995-6003.
9. Hobby P, Gardas A, Radomski R, McGregor AM, Banga JP, Sutton BJ 2000 Identification of an immunodominant region recognized by human autoantibodies in a three-dimensional model of thyroid peroxidase. Endocrinology 141:2018-2026.
10. Gora M, Gardas A, Wiktorowicz W, Hobby P, Watson PF, Weetman AP, Sutton BJ, Banga JP 2004 Evaluation of conformational epitopes on thyroid peroxidase by antipeptide antibody binding and mutagenesis. Clin Exp Immunol 136:137-144.
11. Gora M, Gardas A, Watson PF, Hobby P, Weetman AP, Sutton BJ, Banga JP 2004 Key residues contributing to dominant conformational autoantigenic epitopes on thyroid peroxidase identified by mutagenesis. Biochem Biophys Res Commun 320:795-801.
12. Bresson D, Cerutti M, Devauchelle G, Pugnière M, Roquet F, Bes C, Bossard C, Chardès T, Péraldi-Roux S 2003 Localization of the discontinuous immunodominant region recognized by human anti-thyroperoxidase autoantibodies in autoimmune thyroid diseases. J Biol Chem 278:9560-9569.
13. Bresson D, Pugnière M, Roquet F, Rebuffat SA, N-Guyen B, Cerutti M, Guo J, McLachlan SM, Rapoport B, Estienne V, Ruf J, Chardès T, Péraldi-Roux S 2004 Directed mutagenesis in region 713-720 of human thyroperoxidase assigns 713KFPED717 residues as being involved in the B domain of the discontinuous immunodominant region recognized by human autoantibodies. J Biol Chem 279:39058-39067.
14. Nishikawa T, Rapoport B, McLachlan SM 1996 The quest for the autoantibody immunodominant region on thyroid peroxidase: guided mutagenesis based on a hypothetical three-dimensional model. Endocrinology 137:1000-1006.
15. Guo J, Yan XM, McLachlan SM, Rapoport B 2001 Search for the autoantibody immunodominant region on thyroid peroxidase: epitopic footprinting with a human monoclonal autoantibody locates a facet on the native antigen containing a highly conformational epitope. J Immunol 166:1327-1333.
16. Nishikawa T, Rapoport B, McLachlan SM 1994 Exclusion of two major areas on thyroid peroxidase from the immunodominant region containing the conformational epitopes recognized by human autoantibodies. J Clin Endocrinol Metab 79:1648-1654.
17. Guo J, McLachlan SM, Rapoport B 2002 Localization of the thyroid peroxidase autoantibody immunodominant region to a junctional region containing portions of the domains homologous to complement control protein and myeloperoxidase. J Biol Chem 277:40189-40195.
18. Nishikawa T, Nagayama Y, Seto P, Rapoport B 1993 Human thyroid peroxidase-myeloperoxidase chimeric molecules: tools for the study of antigen recognition by thyroid peroxidase autoantibodies. Endocrinology 133:2496-2501.
19. Kimura S, Kotani T, McBride OW, Umeki K, Hirai K, Nakayama T, Ohtaki S 1987 Human thyroid peroxidase: complete cDNA and protein sequence, chromosome mapping, and identification of two alternately spliced mRNAs. Proc Natl Acad Sci USA 84:5555-5559.
20. Le Fourn V, Ferrand M, Franc JL 2005 Endoproteolytic cleavage of human thyroperoxidase: role of the propeptide in the protein folding process. J Biol Chem 280:4568-4577.
21. Ruf J, Carayon P 2006 Structural and functional aspects of thyroid peroxidase. Arch Biochem Biophys 445:269-277.
22. Fayadat L, Niccoli-Sire P, Lanet J, Franc JL 1998 Human thyroperoxidase is largely retained and rapidly degraded in the endoplasmic reticulum. Its N-glycans are required for folding and intracellular trafficking. Endocrinology 139:4277-4285.
23. Kuliawat R, Ramos-Castañeda J, Liu Y, Arvan P 2005 Intracellular trafficking of thyroid peroxidase to the cell surface. J Biol Chem 280:27713-27718.
24. Zhang X, Arvan P 2000 Cell type-dependent differences in thyroid peroxidase cell surface expression. J Biol Chem 275:31946-31953.
25. Fayadat L, Siffroi-Fernandez S, Lanet J, Franc JL 2000 Calnexin and calreticulin binding to human thyroperoxidase is required for its first folding step (s) but is not sufficient to promote efficient cell surface expression. Endocrinology 141:959-966.
26. Le Fourn V, Siffroi-Fernandez S, Ferrand M, Franc JL 2006 Competition between calnexin and BiP in the endoplasmic reticulum can lead to the folding or degradation of human thyroperoxidase. Biochemistry 45:7380-7388.
27. Gardas A, Lewartowska A, Sutton BJ, Pasieka Z, McGregor AM, Banga JP 1997 Human thyroid peroxidase (TPO) isoforms, TPO-1 and TPO-2: analysis of protein expression in Graves' thyroid tissue. J Clin Endocrinol Metab 82:3752-3757.
28. Ferrand M, Le Fourn V, Franc JL 2003 Increasing diversity of human thyroperoxidase generated by alternative splicing. Characterized by molecular cloning of new transcripts with single- and multispliced mRNAs. J Biol Chem 278:3793-3800.
29. McIntosh RS, Asghar MS, Kemp EH, Watson PF, Gardas A, Banga JP, Weetman AP 1997 Analysis of immunoglobulin G kappa antithyroid peroxidase antibodies from different tissues in Hashimoto's thyroiditis. J Clin Endocrinol Metab 82:3818-3825.
30. Ewins DL, Barnett PS, Tomlinson RW, McGregor AM, Banga JP 1992 Mapping epitope specificities of monoclonal antibodies to thyroid peroxidase using recombinant antigen preparations. Autoimmunity 11:141-149.
31. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR 1989 Sitedirected mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59.
32. Fortunato RS, Lima De Souza EC, Ameziane-el Hassani R, Boufraqech M, Weyemi U, Talbot M, Lagente-Chevallier O, De Carvalho DP, Bidart JM, Schlumberger M, Dupuy C 2010 Functional consequences of dual oxidase-thyroperoxidase interaction at the plasma membrane. J Clin Endocrinol Metab 95:5403-5411.
33. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG 2007 Clustal W and Clustal X version 2.0. Bioinformatics 23:2947-2948.
34. Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, Shen MY, Pieper U, Sali A 2007 Comparative protein structure modeling using MODELLER. Curr Protoc Protein Sci Chapter 2: Unit 2.9.
35. Hess B, Kutzner C, Van Der Spoel D, Lindahl E 2008 GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. Journal of Chemical Theory and Computation 4:435-447.
36. Oostenbrink C, Villa A, Mark AE, Van Gunsteren WF 2004 A biomolecular force field based on the free enthalpy of hydration and solvation. J Comput Chem 25:1656-1676.
37. Berendsen HJC, Postma JPM, Van Gunsteren WF 1981 Interaction models for water in relation to protein hydration. In: Pullman B (ed) Intermolecular Forces. Reidel, Dordrecht, The Netherlands, pp 331-342.
38. Berendsen HJC, Postma JPM, Vangunsteren WF, Dinola A, Haak JR 1984 Molecular-dynamics with coupling to an external bath. J Chem Phys 81:3684-3690.
39. Hess B, Bekker H, Berendsen HJC, Fraaije JGE M 1997 LINCS: A linear constraint solver for molecular simulations. J Comput Chem 18:1463-1472.
40. Miyamoto S, Kollman PA 1992 Settle-an analytical version of the SHAKE and RATTLE algorithm for rigid water models. J Comput Chem 13:952-962.
41. Tironi IG, Sperb R, Smith PE, Vangunsteren WF 1995 A generalized reaction field method for molecular-dynamics simulations. J Chem Phys 102:5451-5459.
42. Heinz TN, Van Gunsteren WF, Hunenberger PH 2001 Comparison of four methods to compute the dielectric permittivity of liquids from molecular dynamics simulations. J Chem Phys 115:1125-1136.
43. Hansson M, Olsson I, Nauseef WM 2006 Biosynthesis, processing, and sorting of human myeloperoxidase. Arch Biochem Biophys 445:214-224.
44. Linding R, Jensen LJ, Diella F, Bork P, Gibson TJ, Russell RB 2003 Protein disorder prediction: implications for structural proteomics. Structure 11:1453-1459.
45. Buchan DW, Ward SM, Lobley AE, Nugent TC, Bryson K, Jones DT 2010 Protein annotation and modelling servers at University College London. Nucleic Acids Res 38:W563-W568.
46. Fayadat L, Siffroi-Fernandez S, Lanet J, Franc JL 2000 Degradation of human thyroperoxidase in the endoplasmic reticulum involves two different pathways depending on the folding state of the protein. J Biol Chem 275:15948-15954.
47. Giraud A, Lejeune PJ, Barbaria J, Mallet B 2007 A plasminogenlike protease in thyroid rough microsomes degrades thyroperoxidase and thyroglobulin. Endocrinology 148:2886-2893.
48. Andersson E, Hellman L, Gullberg U, Olsson I 1998 The role of the propeptide for processing and sorting of human myeloperoxidase. J Biol Chem 273:4747-4753.
49. Bülow E, Nauseef WM, Goedken M, McCormick S, Calafat J, Gullberg U, Olsson I 2002 Sorting for storage in myeloid cells of nonmyeloid proteins and chimeras with the propeptide of myeloperoxidase precursor. J Leukoc Biol 71:279-288.
50. Bening U, Castino R, Harth N, Isidoro C, Hasilik A 1998 Lysosomal segregation of a mannose-rich glycoprotein imparted by the prosequence of myeloperoxidase. J Cell Biochem 71:158-168.
51. Fragoso MA, Torbati A, Fregien N, Conner GE 2009 Molecular heterogeneity and alternative splicing of human lactoperoxidase. Arch Biochem Biophys 482:52-57.
52. Helenius A, Aebi M 2004 Roles of N-linked glycans in the endoplasmic reticulum. Annu Rev Biochem 73:1019-1049.
53. Ungar D 2009 Golgi linked protein glycosylation and associated diseases. Semin Cell Dev Biol 20:762-769.
54. Fayadat L, Niccoli-Sire P, Lanet J, Franc JL 1999 Role of heme in intracellular trafficking of thyroperoxidase and involvement of H2O2 generated at the apical surface of thyroid cells in autocatalytic covalent heme binding. J Biol Chem 274:10533-10538.
55. Nauseef WM, McCormick S, Yi H 1992 Roles of heme insertion and the mannose-6-phosphate receptor in processing of the human myeloid lysosomal enzyme, myeloperoxidase. Blood 80:2622-2633.
56. Chen YJ, Inouye M 2008 The intramolecular chaperonemediated protein folding. Curr Opin Struct Biol 18:765-770.
57. Shinde U, Inouye M 2000 Intramolecular chaperones: polypeptide extensions that modulate protein folding. Semin Cell Dev Biol 11:35-44.
58. Almog O, Gallagher T, Tordova M, Hoskins J, Bryan P, Gilliland GL 1998 Crystal structure of calcium-independent subtilisin BPN with restored thermal stability folded without the prodomain. Proteins 31:21-32.